Drug Profile
Insulin-like growth factor-1 gene therapy - Valentis
Alternative Names: IGF-1 gene therapy - Valentis; Somatomedin-1 gene therapy - ValentisLatest Information Update: 31 Aug 2007
Price :
$50
*
At a glance
- Originator Valentis
- Class Antihyperglycaemics; Gene therapies; Growth factors
- Mechanism of Action Gene transference; Insulin-like growth factor I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic neuropathies; Genitourinary disorders; Postmenopausal osteoporosis